Search for: "Janssen Research " Results 141 - 160 of 201
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Aug 2012, 9:59 pm by Linda Moss
Here’s another discouraging setback in the research for a cure for Alzheimer’s disease. [read post]
3 Aug 2012, 12:27 pm by Morse, Barnes-Brown Pendleton
The deal is an expansion of an existing partnership between Evotec and the Harvard lab of Douglas Melton known as the CureBeta research and development program, created [...] [read post]
18 Jul 2012, 3:58 pm
Unfortunately, some researchers and consumer advocates believe Xarelto may have similar side effects to Pradaxa. [read post]
18 Jul 2012, 2:59 am
"We must do more to protect our children from this dangerous chemical and the FDA must continue to aggressively pursue further research and action on BPA to protect the public health. [read post]
5 Jun 2012, 2:24 am by Sean Patrick Donlan
Minnesota Legal Studies Research Paper No. 12-20. [read post]
31 Mar 2012, 2:59 am
"NRDC scientist Sara Janssen expressed disappointment in the agency's decision: "BPA is a toxic chemical that has no place in our food supply. [read post]
28 Mar 2012, 2:59 am
""FDA has a responsibility to protect the public's health and one step they must take to fulfill their mission is banning BPA as a food additive," said Sarah Janssen, an NRDC scientist. [read post]
13 Feb 2012, 3:04 pm by Mark Zamora
Researchers at J&J’s Janssen unit knew as early as 1999that a study found Risperdal caused diabetes at a higher ratethan a competing drug and failed to hand over the results toregulators probing links between the disease and anti-psychoticmedicines.Source:  http://www.bloomberg.com/news/2012-02-02/j-j-hid-risperdal-studies-to-boost-drug-sales-lawyer-says-at-n-j-trial.html [read post]
11 Feb 2012, 2:37 pm
There are already serious problems with Zarelto that are being raised by researchers, doctors, and yes, plaintiffs' lawyers. [read post]
9 Dec 2011, 1:59 am
Sarah Janssen, senior scientist at the NRDC. [read post]
2 Nov 2011, 2:00 am by Marie Louise
Research & Diagnostic Systems (Pharma Patents) US: Roundup Ready® Soybeans: Patent exhaustion in self-replicating biotechnologies (IP Osgoode) US: FDA continues efforts to expand power over intrastate commerce (FDA Law Blog) US: Defendants’ persistence in pursuing “baseless inequitable conduct claim” justified award of attorneys’ fees to plaintiff: Pfizer et. al v. [read post]
7 Jul 2011, 10:00 am by Lucas A. Ferrara, Esq.
Xarelto is marketed in the U.S. by Raritan, N.J.- based Janssen Pharmaceuticals, Inc., a member of the Janssen Pharmaceutical Companies of Johnson & Johnson. [read post]
4 May 2011, 7:52 am by Tron Emptage
Barry Lipton, Chris Laws and Linda Li, “Narcotics in Workers Compensation,” NCCI Research Brief, December 2009 p.5. 8. [read post]
28 Apr 2011, 3:18 pm by Bexis
By now Restatement (Second) of Torts §402A (1965) is so old as to be thought of as somewhat antediluvian. [read post]
18 Apr 2011, 5:51 pm by FDABlog HPM
  Linda, who will primarily assist HP&M’s drug development group, brings significant experience and expertise in shaping regulatory policies, particularly Comparative Effectiveness Research, Personalized Medicine, and Evidence-Based Medicine. [read post]